FR2355501B1 - - Google Patents

Info

Publication number
FR2355501B1
FR2355501B1 FR7719509A FR7719509A FR2355501B1 FR 2355501 B1 FR2355501 B1 FR 2355501B1 FR 7719509 A FR7719509 A FR 7719509A FR 7719509 A FR7719509 A FR 7719509A FR 2355501 B1 FR2355501 B1 FR 2355501B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7719509A
Other languages
French (fr)
Other versions
FR2355501A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of FR2355501A1 publication Critical patent/FR2355501A1/fr
Application granted granted Critical
Publication of FR2355501B1 publication Critical patent/FR2355501B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7719509A 1976-06-24 1977-06-24 Nouvelles 2-(ethyl 2,2-disubstitue)-imidazolines, utiles notamment pour le traitement du diabete Granted FR2355501A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51074668A JPS5936885B2 (ja) 1976-06-24 1976-06-24 糖尿病治療剤

Publications (2)

Publication Number Publication Date
FR2355501A1 FR2355501A1 (fr) 1978-01-20
FR2355501B1 true FR2355501B1 (Direct) 1980-05-09

Family

ID=13553832

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7719509A Granted FR2355501A1 (fr) 1976-06-24 1977-06-24 Nouvelles 2-(ethyl 2,2-disubstitue)-imidazolines, utiles notamment pour le traitement du diabete

Country Status (5)

Country Link
US (1) US4138491A (Direct)
JP (1) JPS5936885B2 (Direct)
DE (1) DE2728589C3 (Direct)
FR (1) FR2355501A1 (Direct)
PH (1) PH14847A (Direct)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61194020A (ja) * 1985-02-22 1986-08-28 Dai Ichi Seiyaku Co Ltd 網膜症治療剤
CA1309027C (en) * 1987-04-27 1992-10-20 Yasumasa Yoshie Antiasthmatic agent containing imidazoline derivative
DK344489D0 (da) * 1989-07-12 1989-07-12 Novo Nordisk As Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
DE4201709A1 (de) * 1992-01-23 1993-07-29 Bayer Ag (alpha)-aryl-(alpha)-hydroxy-ss-imidazolinyl-propionsaeureamide
IT1276130B1 (it) 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
WO2002038559A1 (en) * 2000-11-10 2002-05-16 Novo Nordisk A/S 1,3-diazaheterocyclic compounds and their use as oral hypoglycaemic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH283583A (de) * 1949-02-24 1952-06-15 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung eines neuen Imidazolinabkömmlings.
US2676964A (en) * 1950-06-07 1954-04-27 Schering Corp 3-pyridyl propylamine antihistamine substances
US2604473A (en) * 1950-07-17 1952-07-22 Schering Corp Propylamine type antihistamines

Also Published As

Publication number Publication date
PH14847A (en) 1981-12-16
FR2355501A1 (fr) 1978-01-20
US4138491A (en) 1979-02-06
DE2728589B2 (de) 1978-10-19
DE2728589C3 (de) 1979-06-07
JPS5936885B2 (ja) 1984-09-06
JPS52156932A (en) 1977-12-27
DE2728589A1 (de) 1978-01-05

Similar Documents

Publication Publication Date Title
FR2355054B1 (Direct)
FR2352324B1 (Direct)
FR2355501B1 (Direct)
JPS5384331U (Direct)
JPS5721705Y2 (Direct)
JPS5332268U (Direct)
JPS5339925Y2 (Direct)
JPS5353236Y2 (Direct)
JPS562983Y2 (Direct)
JPS5758871B2 (Direct)
JPS5650740Y2 (Direct)
DK140439C (Direct)
JPS5641175B2 (Direct)
JPS543998B2 (Direct)
JPS5354774U (Direct)
JPS52113134U (Direct)
JPS5392609U (Direct)
JPS52115261U (Direct)
JPS5381690U (Direct)
DD127089A1 (Direct)
DD126351A1 (Direct)
DD123548A1 (Direct)
CH607740GA3 (Direct)
DD120648A1 (Direct)
CH607443A5 (Direct)

Legal Events

Date Code Title Description
ST Notification of lapse